Lluís Montoliu

Lluís Montoliu

Lluís Montoliu
Cargo

Research professor at the National Biotechnology Centre (CNB-CSIC) and at the CIBERER-ISCIII

 

Reactions: macaque embryo-like structures developed and implanted in utero from stem cells

Chinese researchers have succeeded in developing macaque embryo-like structures from embryonic stem cells. They have also managed to implant them in the uterus of female macaque monkeys and develop a hormonal response similar to that of a gestation, although they have only survived for about a week. According to the authors, whose research is published in Cell Stem Cell, these models could be used to improve our understanding of embryonic development and to investigate the causes of some early miscarriages.

 

0

A brief guide to inform and educate about rare diseases

Every February 28 or 29, World Rare Disease Day is celebrated, an initiative that aims to raise awareness about rare diseases in order to improve access to diagnosis and treatment and achieve a better quality of life among those who suffer from them. Here are some frequently asked questions about the most important concepts, their current situation and the main complaints that affected individuals and families continue to have.   

0

The story of CRISPR in the last ten, twenty and thirty years

In January 2013, two laboratories demonstrated that CRISPR tools could be used to edit genes in human cells. Ten years later, the first patients are already benefiting from the molecular scissors to overcome incurable diseases. This week in Science, one of the pioneers of CRISPR, Nobel laureate Jennifer Doudna, summarises the history of these tools, without forgetting that it all began thirty years ago with the findings of Francis Mojica in the Santa Pola salt flats.

1

Reaction: CRISPR used to protect mice from heart disease

Ischaemia-reperfusion injury is one of the causes of damage caused by diseases such as myocardial infarction. A study published in the journal Science has used base editors, a gene-editing tool derived from CRISPR, to modify a key protein in the hearts of mice. According to the authors, the intervention allowed them to recover their function after a heart attack and could potentially be used in a wide range of patients, as it does not depend on the presence of a specific mutation.

0

Reactions to the new mapping of rare disease diagnoses in Spain since 1960

A team of researchers from the Health Institute Carlos III has published an article quantifying the diagnostic delay of rare diseases in Spain with data from the period 1960-2021. The study reveals that more than half of the patients experienced a delay in diagnosis, that the average delay exceeds six years, and that both the percentage of those affected by the delay and the average time have decreased over the years.

0